These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8540445)
21. Use of ATP-MgCl2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects. Brook MM; Fineman JR; Bolinger AM; Wong AF; Heymann MA; Soifer SJ Circulation; 1994 Sep; 90(3):1287-93. PubMed ID: 8087937 [TBL] [Abstract][Full Text] [Related]
22. Atrial natriuretic peptide: could it be a marker for postoperative recurrent effusions after Fontan circulation in complex congenital heart defects? Alkan T; Sarioğlu A; Samanli UB; Sarioğlu T; Akçevin A; Türkoğlu H; Paker T; Aytaç A ASAIO J; 2006; 52(5):543-8. PubMed ID: 16966855 [TBL] [Abstract][Full Text] [Related]
23. Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease. Kovalchin JP; Mott AR; Rosen KL; Feltes TF Tex Heart Inst J; 1997; 24(4):308-16. PubMed ID: 9456484 [TBL] [Abstract][Full Text] [Related]
24. Circulating High Mobility Group Box-1 Does Not Predict Pulmonary Arterial Hypertension in Children with Congenital Heart Disease: A Prospective Cohort Study. Caracci B; Pehora C; Benson L; Steinberg BE; Goldenberg NM; Taylor K J Cardiothorac Vasc Anesth; 2024 Oct; 38(10):2356-2361. PubMed ID: 39095209 [TBL] [Abstract][Full Text] [Related]
26. Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension. Weesner KM Cathet Cardiovasc Diagn; 1991 Sep; 24(1):10-5. PubMed ID: 1913785 [TBL] [Abstract][Full Text] [Related]
27. Effect of pH and PCO2 on pulmonary and systemic hemodynamics after surgery in children with congenital heart disease and pulmonary hypertension. Morray JP; Lynn AM; Mansfield PB J Pediatr; 1988 Sep; 113(3):474-9. PubMed ID: 3137318 [TBL] [Abstract][Full Text] [Related]
28. Plasma atrial natriuretic peptide levels in children with cardiac diseases: correlation with cGMP levels and haemodynamic parameters. Weil J; Strom TM; Brangenberg R; Sebening W; Haufe M; Lang RE; Bidlingmaier F; Gerzer R Horm Res; 1987; 28(1):64-70. PubMed ID: 2834283 [TBL] [Abstract][Full Text] [Related]
29. Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. Adnot S; Chabrier PE; Andrivet P; Viossat I; Piquet J; Brun-Buisson C; Gutkowska Y; Braquet P Am Rev Respir Dis; 1987 Oct; 136(4):951-6. PubMed ID: 2959183 [TBL] [Abstract][Full Text] [Related]
30. Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects. Rabinovitch M; Andrew M; Thom H; Trusler GA; Williams WG; Rowe RD; Olley PM Circulation; 1987 Nov; 76(5):1043-52. PubMed ID: 3117409 [TBL] [Abstract][Full Text] [Related]
31. Plasma and right auricle concentrations of atrial natriuretic polypeptide in children with cardiac diseases. Akimoto K; Miyata A; Kangawa K; Matsuo H; Koga Y; Matsuoka Y; Hayakawa K Eur J Pediatr; 1988 Jun; 147(5):485-9. PubMed ID: 2970389 [TBL] [Abstract][Full Text] [Related]
32. Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension. Turanlahti MI; Laitinen PO; Sarna SJ; Pesonen E Heart; 1998 Feb; 79(2):169-74. PubMed ID: 9538311 [TBL] [Abstract][Full Text] [Related]
33. Effects of oxygen and nitric oxide in oxygen on pulmonary arterial pressures of children with congenital cardiac defects. Allman KG; Young JD; Carapiet D; Stevens JE; Ostman-Smith I; Archer LN Pediatr Cardiol; 1996; 17(4):246-50. PubMed ID: 8662048 [TBL] [Abstract][Full Text] [Related]
34. [Changes in oxygenation indexes with the use of nitric oxide in the postoperative period of congenital heart disease surgery in patients with severe pulmonary hypertension]. Ramírez Ramírez L; Calderón Colmenero J; Zarco Martínez E; García Montes JA; Molina Méndez J; Fernández de la Reguera G Arch Cardiol Mex; 2001; 71(2):121-6. PubMed ID: 11565303 [TBL] [Abstract][Full Text] [Related]
35. Nitric oxide level in children with pulmonary hypertension. Narin F; Narin N; Pasaoglu H; Uzüm K; Erdogan R Indian J Physiol Pharmacol; 2000 Jul; 44(3):335-9. PubMed ID: 10941623 [TBL] [Abstract][Full Text] [Related]
36. Does inhaled nitric oxide improve survival in operated congenital disease with severe pulmonary hypertension? Sharma R; Raizada N; Choudhary SK; Bhan A; Kumar P; Juneja R; Kothari SS; Saxena A; Venugopal P Indian Heart J; 2001; 53(1):48-55. PubMed ID: 11456141 [TBL] [Abstract][Full Text] [Related]
37. Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis. Atz AM; Adatia I; Jonas RA; Wessel DL Am J Cardiol; 1996 Feb; 77(4):316-9. PubMed ID: 8607419 [TBL] [Abstract][Full Text] [Related]
38. Association of nitric oxide dose and methemoglobin levels in patients with congenital heart disease and pulmonary hypertension. Riddle EM; Feltes TF; Rosen K; Fraley JK; Mott AR; Kovalchin JP Am J Cardiol; 2002 Aug; 90(4):442-4. PubMed ID: 12161242 [No Abstract] [Full Text] [Related]
39. Relationship between left atrial pressure and atrial natriuretic peptide in children with cardiac disease. Huang TY; Dai ZK; Wu JR; Huang MY Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Apr; 11(4):197-204. PubMed ID: 7602654 [TBL] [Abstract][Full Text] [Related]
40. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1. Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]